H C Starck is a leading international manufacturer of high-technology powders and components made of technology metals, advanced ceramics and thermal spray powders. H.C. Starck contributes to improvements in the quality of life with our business activities, products and services, and creates value that benefits our customers, shareholders, employees, suppliers and the public.
The UK Modern Slavery Act 2015 (the “Act”) creates offences and imposes a duty on businesses supplying goods and services in the UK to report each year on the steps they have undertaken to ensure their operations and supply chains are free of human trafficking and slavery. H.C. Starck does not and will not use forced, indentured or involuntary labor in any of its operations and will not knowingly utilize any supplier suspected of doing so.
H.C. Starck Group and its subsidiary companies (H.C. Starck) are committed to essential ethical standards. This commitment is not new. H.C. Starck maintains robust supply chain management systems that seeks to ensure, through regular verification, audit and certification that its raw materials are sourced in a socially responsible manner that does not support those engaged in human trafficking.
H.C. Starck’s Code of Business Ethics states the company’s commitment to uphold all internationally-recognized human rights, such as the United Nations Guiding Principles on Business and Human Rights. More specifically, H.C. Starck is committed to ensuring its operations and supply chains are free of human trafficking and slavery and has implemented and utilizes a supply chain management system that monitors and audits high risk areas and potential affected populations. H.C. Starck also requires its suppliers to take all necessary steps to demonstrate that their operations and their supply chains strictly comply with these commitments.
This statement is made pursuant to section 54(1) of the Act and constitutes the slavery and human trafficking statement for the financial years ending December 2015 and December 2016 for H.C. Starck and its subsidiaries to which the Act applies. Signed on the Board's behalf by:Dr. Jens Knoell
Questions regarding this statement should be directed to the H.C. Starck Legal Department